Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D C Giunchi

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
Tumori|October 31, 1986
Combination chemotherapy in advanced ovarian carcinomaD Amadori, A Ravaioli, M Maltoni, et al.
Breast Cancer Research and Treatment|March 1, 1997
Cell proliferation as a predictor of response to chemotherapy in metastatic breast cancer: a prospective studyD Amadori, A Volpi, R Maltoni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 30, 2000
Disease-free survival advantage of adjuvant cyclophosphamide, methotrexate, and fluorouracil in patients with node-negative, rapidly proliferating breast cancer: a randomized multicenter studyD Amadori, O Nanni, M Marangolo, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
Tumori|October 31, 1986
Combination chemotherapy in advanced ovarian carcinomaD Amadori, A Ravaioli, M Maltoni, et al.
Breast Cancer Research and Treatment|March 1, 1997
Cell proliferation as a predictor of response to chemotherapy in metastatic breast cancer: a prospective studyD Amadori, A Volpi, R Maltoni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 30, 2000
Disease-free survival advantage of adjuvant cyclophosphamide, methotrexate, and fluorouracil in patients with node-negative, rapidly proliferating breast cancer: a randomized multicenter studyD Amadori, O Nanni, M Marangolo, et al.
Pageof 1